AB0286 LONG-TERM EFFECTS OF WEIGHT RESTORATION ON BONE MINERAL DENSITY (BMD) IN PATIENTS WITH ANOREXIA NERVOSA

Background:Anorexia nervosa is an eating disorder characterized by extremely low body mass index (BMI) with consequent low bone mineral density (BMD) and higher risk of fractures.Objectives:To investigate the long-term effects of body weight restoration on BMD in patients with anorexia nervosa.Metho...

Full description

Saved in:
Bibliographic Details
Published inAnnals of the rheumatic diseases Vol. 83; no. Suppl 1; pp. 1386 - 1387
Main Authors Adami, G., Fassio, A., Simona, C., Molgora, M., Chimini, M., Segattini, B., Gatti, D., Rossini, M., Dalle Grave, A., Dalle Grave, R.
Format Journal Article
LanguageEnglish
Published Kidlington BMJ Publishing Group Ltd and European League Against Rheumatism 01.06.2024
Elsevier B.V
Elsevier Limited
Subjects
Online AccessGet full text
ISSN0003-4967
1468-2060
DOI10.1136/annrheumdis-2024-eular.2655

Cover

Loading…
More Information
Summary:Background:Anorexia nervosa is an eating disorder characterized by extremely low body mass index (BMI) with consequent low bone mineral density (BMD) and higher risk of fractures.Objectives:To investigate the long-term effects of body weight restoration on BMD in patients with anorexia nervosa.Methods:We conducted a prospective observational study of patients with anorexia nervosa admitted to an eating disorder clinic for intensive weight restoration program, inpatient (20-week program) followed by an outpatient long-term follow-up. Clinical, demographic, body composition and BMD data were collected at baseline (admission), at week 20 (W20) and after >5 years.Results:53 women were enrolled in the study. Mean age at baseline was 32±9.2 years and the median follow-up was 8.0 years (IQR 9.1-7.0). Mean BMI at baseline was 15.8±1.7. Lumbar spine BMD Z-score at baseline was -0.72±1.14, femoral neck Z-score at baseline was -0.37±0.97 and total hip Z-score at baseline was -0.40±1.06. All patients had normal (>20 ng/mL) 25-OH-vitamin D levels throughout the study. All subjects achieved BMI ≥18 at W20 and in aggregate BMD increased at all sites at W20. However, after a median follow-up of 8.1 years (IQR 7.3-8.6), 14 patients had BMI <18 (weight loss after discharge – in red in the figures), whereas 39 subjects kept BMI ≥18 over a median follow-up of 8.0 years (IQR 6.9-9.2), in blue in the figures. Figure 1 shows the cumulative probability of losing BMD at various sites stratified by maintenance of BMI above or below the threshold of 18. Figure 2 shows the trend in BMD levels at the femur and lumbar spine in patients that maintained BMI≥18 or <18.Figure 1.Figure 2.Conclusion:In aggregate, short-term weight restoration was associated with a significant increase in BMD at all sites. Keeping BMI ≥18 in the long term was associated with a positive non-plateau effect on lumbar spine BMD. In contrast, weight loss after discharge was associated with a significant bone loss at all sites.REFERENCES:NIL.Acknowledgements:NIL.Disclosure of Interests:Giovanni Adami Theramex, UCB, Lilly, Galapagos, Fresenius Kabi, Amgen, BMS, Abiogen and Pfizer, Angelo Fassio: None declared, Calugi Simona: None declared, Manuela Molgora: None declared, Mirko Chimini: None declared, Barbara Segattini: None declared, Davide Gatti: None declared, Maurizio Rossini: None declared, Anna Dalle Grave: None declared, Riccardo Dalle Grave: None declared.
Bibliography:EULAR 2024 European Congress of Rheumatology, 12-15 June. Vienna, Austria
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0003-4967
1468-2060
DOI:10.1136/annrheumdis-2024-eular.2655